Comparable stake leader
Anthony DiGiandomenico
SEC ownership of ENDRA Life Sciences Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001681682.
Disclosed value leader
Anthony DiGiandomenico
Comparable rows
5/21
Latest evidence
31 Mar 2026
- Public ticker
- NDRA on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Anthony DiGiandomenico
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
5 of 21
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Anthony DiGiandomenico
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001681682
- Issuer location
- Ann Arbor, MI
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ENDRA Life Sciences Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anthony DiGiandomenico
Disclosed value leader
Anthony DiGiandomenico
Comparable rows
5/21
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 10%
16 rows are not safely comparable across share classes.
13D/G row: Anthony DiGiandomenico
Showing 1-8 of 21 holder rows.
Quick read
Anthony DiGiandomenico leads the comparable SEC ownership view at 10%.
5 of 21 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Anthony DiGiandomenico's linked filing trail.
Comparable ownership
Top 5
Anthony DiGiandomenico
10%
John C. Lipman
10%
ATW Partners Opportunities Manage...
9.9%
L1 Capital Global Opportunities M...
3%
S.H.N. Financial Investments Ltd.
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 21 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anthony DiGiandomenico |
3/4/5
13D/G
Director
|
10%
from 13D/G
|
$1,691,146
278,233 shares
mixed-class rows
|
— | 21 Jan 2026 |
| John C. Lipman |
13D/G
John Carter Lipman
|
10%
|
—
115,477 shares
|
$0 | 23 Oct 2025 |
| ATW Partners Opportunities Management, LLC |
13D/G
ATW Master Fund V LP
|
9.9%
|
—
116,024 shares
|
$0 | 16 Oct 2025 |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
3%
|
—
35,589 shares
|
$0 | 14 Nov 2025 |
| S.H.N. Financial Investments Ltd. |
13D/G
|
3%
|
—
35,588 shares
|
$0 | 14 Nov 2025 |
| Alexander Y. Tokman |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$359,798
101,926 shares
|
— | 02 Mar 2026 |
| Michael Harsh |
3/4/5
Director
|
—
class O/S missing
|
$332,492
65,710 shares
|
— | 21 Jan 2026 |
| Lou Basenese |
3/4/5
Director
|
—
class O/S missing
|
$332,487
65,709 shares
|
— | 21 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 17 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to ENDRA Life Sciences Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Anthony DiGiandomenico
Net 12M change
$0
Latest report
02 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anthony DiGiandomenico | Director | $1,691,146 | Mixed | 21 Jan 2026 | ||
| Alexander Y. Tokman | Chief Executive Officer, Director | $359,798 | Mixed | 02 Mar 2026 | ||
| Michael Harsh | Director | $332,492 | Mixed | 21 Jan 2026 | ||
| Lou Basenese | Director | $332,487 | Mixed | 21 Jan 2026 | ||
| Richard Jacroux | Chief Financial Officer | $118,117 | Mixed | 02 Mar 2026 | ||
| Michael Milos Thornton | Chief Technology Officer | $56,329 | Filing P/S | 18 May 2023 | ||
| Renaud Bertrand Maloberti | Chief Commercial Officer | Mixed | 28 Mar 2022 | |||
| UBS Group AG | Market maker/broker-dealer | Mixed | 27 Aug 2024 | |||
| Francois Roger Michelon | Chief Executive Officer, Director | Mixed | 30 Jan 2023 | |||
| Irina Pestrikova | Senior Director, Finance | Mixed | 30 Jan 2023 |
Recent insider transactions for ENDRA Life Sciences Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alexander Y. Tokman | NDRA | Common Stock | Award | 35.9% | 26,921 | 101,926 | 02 Mar 2026 | Direct | ||
| Richard Jacroux | NDRA | Common Stock | Award | 67.3% | 13,461 | 33,461 | 02 Mar 2026 | Direct | ||
| Michael Harsh | NDRA | Common Stock | Award | 1120% | 60,324 | 65,710 | 21 Jan 2026 | Direct | ||
| Richard Jacroux | NDRA | Common Stock | Award | 20,000 | 20,000 | 21 Jan 2026 | Direct | |||
| Lou Basenese | NDRA | Common Stock | Award | 1120.2% | 60,324 | 65,709 | 21 Jan 2026 | Direct | ||
| Alexander Y. Tokman | NDRA | Common Stock | Award | 1500000% | 75,000 | 75,005 | 21 Jan 2026 | Direct | ||
| Anthony Digiandomenico | NDRA | Common Stock | Award | 79.1% | 60,324 | 136,589 | 21 Jan 2026 | Direct | ||
| Anthony Digiandomenico | NDRA | Common Stock | Award | 1301.2% | 70,822 | 76,265 | 10 Oct 2025 | Direct | ||
| Anthony Digiandomenico | NDRA | Warrants | Award | 141,644 | 141,644 | 10 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.